Immunosuppressive therapy before and during pregnancy may improve obstetric outcomes in pregnancy complicated by dermatomyositis with anti-MDA-5 antibody positivity: A case report

• Main Authors: Hiroyuki Goto (Author), Kimito Kawahata (Author), Akiko Shida (Author), Saeko Nakagane (Author), Hitoshi Isohata (Author), Yu Yamazaki (Author), Yoshihiro Yoshimura (Author), Kyoko Hattori (Author), Kazuki Sekiguchi (Author), Ryuzo Ishikawa (Author), Yoko Onishi (Author), Yuji Kanai (Author), Nobuya Unno (Author), Daigo Ochiai (Author)
• Format: Book
• Published: Elsevier, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dermatomyositis (DM) is one of the most common autoimmune rheumatic diseases affecting women of childbearing age. Pregnancy may lead to exacerbation of DM, especially of DM with anti-melanoma differentiation-associated gene (MDA) 5 antibody positivity, leading to a poor obstetric outcome. Here, we r...